Clinical Trial

A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study primarily aims to assess the efficacy and safety of zonisamide when used as an adjunctive therapy for focal epilepsy. The main questions it aims to answer are: 1. Does the frequency of epileptic seizures decrease after oral zonisamide, and does it improve cognitive function? 2. Are there any treatment-emergent adverse events associated with oral administration of zonisamide?
Trial Details
NCT Number NCT06967012
Lead Sponsor Affiliated Hospital of Nantong University
Conditions Epilepsies, Partial, Epilepsy, Tonic-Clonic
Enrollment 30 participants
Start Date 2024-08-01
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-13